Multispecific aspergillus T cells selected by CD137 or CD154 induce protective immune responses against the most relevant mold infections

Journal of Infectious Diseases

Volumn 211, Issue 8, 2015, Pages 1251-1261

  Stuehler, Claudia ^a   Nowakowska, Justyna ^a   Bernardini, Claudia ^a,b   Topp, Max S ^c   Battegay, Manuel ^b   Passweg, Jakob ^a   Khanna, Nina ^a,b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b Hospital Epidemiology   (United States)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Aspergillus; CD137 and CD154 expression; fungal infection; multispecific T cells; T cell therapy

Indexed keywords

CD137 ANTIGEN; CD40 LIGAND; FUNGAL PROTEIN; PROTEIN CRF1; PROTEIN GEL1; PROTEIN PMP20; UNCLASSIFIED DRUG; FUNGUS ANTIGEN;

ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; CELL SPECIFICITY; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; INVASIVE ASPERGILLOSIS; MOLECULAR RECOGNITION; MUCORALES; MYCOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; TH1 CELL; ADULT; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; FEMALE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MALE; MICROBIOLOGY; MIDDLE AGED; PROCEDURES;

ADULT; ANTIGENS, CD137; ANTIGENS, FUNGAL; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CD40 LIGAND; FEMALE; FUNGAL PROTEINS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; TH1 CELLS;

EID: 84926668073     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu607     Document Type: Article

References (42)

1. Gooley TA, Chien JW, Pergam SA, et al. Reduced mortality after allo-geneic hematopoietic-cell transplantation. N Engl J Med 2010; 363:2091-101.
2. Marr KA. Fungal infections in hematopoietic stem cell transplant recipients. Med Mycol 2008; 46:293-302.
3. Perruccio K, Tosti A, Burchielli E, et al. Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation. Blood 2005; 106:4397-406.
4. Nierman WC, Pain A, Anderson MJ, et al. Genomic sequence of the pathogenic and allergenic filamentous fungus Aspergillus fumigatus. Nature 2005; 438:1151-6.
5. Stuehler C, Khanna N, Bozza S, et al. Cross-protective TH1 immunity against Aspergillus fumigatus and Candida albicans. Blood 2011; 117:5881-91.
6. Bozza S, Clavaud C, Giovannini G, et al. Immune sensing of Aspergillus fumigatus proteins, glycolipids, and polysaccharides and the impact on Th immunity and vaccination. J Immunol 2009; 183:2407-14.
7. Jolink H, Meijssen IC, Hagedoorn RS, et al. Characterization of the T-cell-mediated immune response against the Aspergillus fumigatus proteins Crf1 and catalase 1 in healthy individuals. J Infect Dis 2013; 208:847-56.
8. Potenza L, Vallerini D, Barozzi P, et al. Characterization of specific immune responses to different Aspergillus antigens during the course of invasive Aspergillosis in hematologic patients. PLoS One 2013; 8: e74326.
9. Bacher P, Kniemeyer O, Teutschbein J, et al. Identification of immuno-genic antigens from Aspergillus fumigatus by direct multiparameter characterization of specific conventional and regulatory CD4+ T cells. J Immunol 2014; 193:3332-43.
10. Chaudhary N, Staab JF, Marr KA. Healthy human T-Cell Responses to Aspergillus fumigatus antigens. PLoS One 2010; 5:e9036.
11. Diaz-Arevalo D, Bagramyan K, Hong TB, Ito JI, Kalkum M. CD4+ T cells mediate the protective effect of the recombinant Asp f3-based anti-aspergillosis vaccine. Infect Immun 2011; 79:2257-66.
12. Jolink H, Hagedoorn RS, Lagendijk EL, et al. Induction of A. fumigatus-specific CD4+ T-cells in patients recovering from invasive aspergillosis. Haematologica 2014; 99:1255-63.
13. Feuchtinger T, Opherk K, Bethge WA, et al. Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation. Blood 2010; 116:4360-7.
14. Moosmann A, Bigalke I, Tischer J, et al. Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells. Blood 2010; 115:2960-70.
15. Peggs KS, Thomson K, Samuel E, et al. Directly selected cytomegalovi-rus-reactive donor T cells confer rapid and safe systemic reconstitution of virus-specific immunity following stem cell transplantation. Clin Infect Dis 2011; 52:49-57.
16. Khanna N, Stuehler C, Conrad B, et al. Generation of a multipathogen-specific T-cell product for adoptive immunotherapy based on activation-dependent expression of CD154. Blood 2011; 118:1121-31.
17. Frentsch M, Arbach O, Kirchhoff D, et al. Direct access to CD4+ T cells specific for defined antigens according to CD154 expression. Nat Med 2005; 11:1118-24.
18. Wolfl M, Kuball J, Ho WY, et al. Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8+ T cells responding to antigen without requiring knowledge of epitope specificities. Blood 2007; 110:201-10.
19. Beck O, Topp MS, Koehl U, et al. Generation of highly purified and functionally active human TH1 cells against Aspergillus fumigatus. Blood 2006; 107:2562-9.
20. Carvalho A, De Luca A, Bozza S, et al. TLR3 essentially promotes protective class I-restricted memory CD8(+) T-cell responses to Aspergillus fumigatus in hematopoietic transplanted patients. Blood 2012; 119:967-77.
21. Nanjappa SG, Heninger E, Wuthrich M, Sullivan T, Klein B. Protective antifungal memory CD8(+) T cells are maintained in the absence of CD4(+) T cell help and cognate antigen in mice. J Clin Invest 2012; 122:987-99.
22. Bozza S, Gaziano R, Lipford GB, et al. Vaccination of mice against invasive aspergillosis with recombinant Aspergillus proteins and CpG oli-godeoxynucleotides as adjuvants. Microbes Infect 2002; 4:1281-90.
23. Hebart H, Bollinger C, Fisch P, et al. Analysis of T-cell responses to As-pergillus fumigatus antigens in healthy individuals and patients with he-matologic malignancies. Blood 2002; 100:4521-8.
24. Seggewiss R, Einsele H. Immune reconstitution after allogeneic transplantation and expanding options for immunomodulation: an update. Blood 2010; 115:3861-8.
25. Ramadan G, Davies B, Kurup VP, Keever-Taylor CA. Generation of Th1T cell responses directed to a HLA Class II restricted epitope from the Aspergillus f16 allergen. Clin Exp Immunol 2005; 139: 257-67.
26. Feuchtinger T, Matthes-Martin S, Richard C, et al. Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adeno-virus infection after allogeneic stem cell transplantation. Br J Haematol 2006; 134:64-76.
27. Icheva V, Kayser S, Wolff D, et al. Adoptive transfer of epstein-barr virus (EBV) nuclear antigen 1-specific t cells as treatment for EBV reactivation and lymphoproliferative disorders after allogeneic stem-cell transplantation. J Clin Oncol 2013; 31:39-48.
28. Romani L. Immunity to fungal infections. Nat Rev Immunol 2011; 11:275-88.
29. Goldstein MJ, Kohrt HE, Houot R, et al. Adoptive cell therapy for lym-phoma with CD4T cells depleted of CD137-expressing regulatory T cells. Cancer Res 2012; 72:1239-47.
30. Snell LM, Lin GH, McPherson AJ, Moraes TJ, Watts TH. T-cell intrinsic effects of GITR and 4-1BB during viral infection and cancer immuno-therapy. Immunol Rev 2011; 244:197-217.
31. Bouzani M, Ok M, McCormick A, et al. Human NK cells display important antifungal activity against Aspergillus fumigatus, which is directly mediated by IFN-gamma release. J Immunol 2011; 187:1369-76.
32. Dejima T, Shibata K, Yamada H, et al. Protective role of naturally occurring interleukin-17A-producing gammadelta T cells in the lung at the early stage of systemic candidiasis in mice. Infect Immun 2011; 79:4503-10.
33. Fenoglio D, Poggi A, Catellani S, et al. Vdelta1T lymphocytes producing IFN-gamma and IL-17 are expanded in HIV-1-infected patients and respond to Candida albicans. Blood 2009; 113:6611-8.
34. Ramadan G. In vitro expansion of human gammadelta and CD56(+) T-cells by Aspergillus-antigen loaded fast dendritic cells in the presence of exogenous interleukin-12. Immunopharmacol Immunotoxicol 2012; 34:309-16.
35. Schmidt S, Tramsen L, Hanisch M, et al. Human natural killer cells exhibit direct activity against Aspergillus fumigatus hyphae, but not against resting conidia. J Infect Dis 2011; 203:430-5.
36. van de Veerdonk FL, Netea MG. T-cell subsets and antifungal host defenses. Curr Fungal Infect Rep 2010; 4:238-43.
37. Locatelli F, Merli P, Rutella S. At the Bedside: Innate immunity as an immunotherapy tool for hematological malignancies. J Leukoc Biol 2013; 94:1141-57.
38. Kontoyiannis DP, Marr KA, Park BJ, et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis 2010; 50:1091-100.
39. Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 2005; 41:634-53.
40. Skiada A, Pagano L, Groll A, et al. Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clin Microbiol Infect 2011; 17:1859-67.
41. van de Veerdonk FL, Kullberg BJ, van der Meer JW, Gow NA, Netea MG. Host-microbe interactions: innate pattern recognition of fungal pathogens. Curr Opin Microbiol 2008; 11:305-12.
42. Gresnigt MS, Bozza S, Becker KL, et al. A polysaccharide virulence factor from Aspergillus fumigatus elicits anti-inflammatory effects through induction of Interleukin-1 receptor antagonist. PLoS Pathog 2014; 10: e1003936.